EA200300005A1 - Соль тиазолидиндиона для лечения сахарного диабета - Google Patents

Соль тиазолидиндиона для лечения сахарного диабета

Info

Publication number
EA200300005A1
EA200300005A1 EA200300005A EA200300005A EA200300005A1 EA 200300005 A1 EA200300005 A1 EA 200300005A1 EA 200300005 A EA200300005 A EA 200300005A EA 200300005 A EA200300005 A EA 200300005A EA 200300005 A1 EA200300005 A1 EA 200300005A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compound
thiazolidindion
salt
treatment
diabetes mellitus
Prior art date
Application number
EA200300005A
Other languages
English (en)
Russian (ru)
Inventor
Эндрю Симон Крейг
Тим Чиен Тинг Хо
Original Assignee
Смитклайн Бичам П.Л.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам П.Л.С. filed Critical Смитклайн Бичам П.Л.С.
Publication of EA200300005A1 publication Critical patent/EA200300005A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
EA200300005A 2000-06-08 2001-06-08 Соль тиазолидиндиона для лечения сахарного диабета EA200300005A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical
PCT/GB2001/002567 WO2001094344A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus

Publications (1)

Publication Number Publication Date
EA200300005A1 true EA200300005A1 (ru) 2003-04-24

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300005A EA200300005A1 (ru) 2000-06-08 2001-06-08 Соль тиазолидиндиона для лечения сахарного диабета

Country Status (23)

Country Link
EP (1) EP1296980A1 (no)
JP (1) JP2003535862A (no)
KR (1) KR20030007918A (no)
CN (1) CN1443186A (no)
AP (1) AP2002002673A0 (no)
AU (1) AU2001264078A1 (no)
BG (1) BG107357A (no)
BR (1) BR0111536A (no)
CA (1) CA2411065A1 (no)
CZ (1) CZ20023966A3 (no)
DZ (1) DZ3382A1 (no)
EA (1) EA200300005A1 (no)
GB (1) GB0014006D0 (no)
HU (1) HUP0301137A3 (no)
IL (1) IL153279A0 (no)
MA (1) MA25753A1 (no)
MX (1) MXPA02012100A (no)
NO (1) NO20025883L (no)
OA (1) OA12284A (no)
PL (1) PL360592A1 (no)
SK (1) SK17142002A3 (no)
WO (1) WO2001094344A1 (no)
ZA (1) ZA200209954B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
EP2016076A2 (en) * 2007-01-22 2009-01-21 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (de) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung eines Benzimidazolderivats
WO2010021745A2 (en) * 2008-08-21 2010-02-25 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
BG107357A (bg) 2003-08-29
CA2411065A1 (en) 2001-12-13
GB0014006D0 (en) 2000-08-02
BR0111536A (pt) 2003-07-01
CZ20023966A3 (cs) 2003-04-16
ZA200209954B (en) 2003-10-10
NO20025883D0 (no) 2002-12-06
HUP0301137A2 (hu) 2003-08-28
DZ3382A1 (fr) 2001-12-13
SK17142002A3 (sk) 2003-10-07
NO20025883L (no) 2003-02-03
HUP0301137A3 (en) 2005-04-28
WO2001094344A1 (en) 2001-12-13
AU2001264078A1 (en) 2001-12-17
AP2002002673A0 (en) 2002-12-31
MXPA02012100A (es) 2003-04-25
EP1296980A1 (en) 2003-04-02
CN1443186A (zh) 2003-09-17
MA25753A1 (fr) 2003-04-01
OA12284A (en) 2003-11-10
JP2003535862A (ja) 2003-12-02
KR20030007918A (ko) 2003-01-23
IL153279A0 (en) 2003-07-06
PL360592A1 (en) 2004-09-20

Similar Documents

Publication Publication Date Title
EA200200975A1 (ru) Гидрохлорид 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси] бензил]тиазолидин-2,4-диона
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
CY1105252T1 (el) Το υδροχλωρικο αλας της 5-[4-[2-(ν-μεθυλο-ν-(2-πυριδυλο)αμινο)-αιθοξυ]βενζυλο]θειαζολιδινο-2,4-διονης
EA200300005A1 (ru) Соль тиазолидиндиона для лечения сахарного диабета
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
EA200300234A1 (ru) Тартратные соли производного тиазолидиндиона
PT1446404E (pt) Edisilatos de rosiglitazona e sua utilizacao como antidiabeticos
EA200101102A1 (ru) Новый фармацевтический препарат
EA200300230A1 (ru) Тартратная соль производного тиазолидиндиона
EA200300004A1 (ru) Гидроиодид 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона в качестве фармацевтического препарата
EA200300423A1 (ru) Производное тиазолидиндиона и его применение в качестве противодиабетического лекарственного средства
EA200300231A1 (ru) Тартратные соли производного тиазолидиндиона
ATE343574T1 (de) Ein thiazolidindionderivat und seine verwendung als antidiabetikum
EA200300232A1 (ru) Тартратные соли производного тиазолидиндиона
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt
EA200300422A1 (ru) Натриевые соли 5-[4-[2-( n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона